Andrew Chen is a drug discovery biologist and biological engineer currently serving as a Senior Scientist in Discovery Oncology at Merck. They previously held notable positions as a Senior Scientist and Research Scientist at Kronos Bio, where they contributed to oncology, immuno-oncology, and autoimmune disease programs. Andrew's earlier experience includes research roles at the Massachusetts Institute of Technology and Bristol-Myers Squibb, where they focused on bioproduction and biologics development. They earned a Ph.D. in Biological Engineering from MIT and a Bachelor's degree from Cornell University, where they also served as a tutor and teaching assistant.
This person is not in any teams
This person is not in any offices